AbbVie Reports Third-Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AbbVie (ABBV) Tops Q3 EPS by 3c, Lifts FY EPS Guidance
October 27, 2017 7:42 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $1.41, $0.03 better than the analyst estimate of $1.38. Revenue for the quarter came in at $7 billion versus the consensus estimate of $7 billion.
GUIDANCE:
AbbVie sees FY2017 EPS of $5.53-$5.55, versus the consensus of $5.53.
Update To... More
